Join FierceBiotech in London on October 30th for our Executive Summit. We’ll discuss a post-Brexit world and what this means for U.K. biomedical science. We'll also look at the burgeoning new digital health industry and how new innovations can help research. And we’ll round out the day with a networking cocktail hour. I hope you can join us. Click here to register. Today's Rundown Roche puts up $125M to expand SQZ cell therapy pact Alnylam drops early filing plan for porphyria drug givosiran New York biotech snaps up Eli Lilly neuro veteran as CSO F-star names ex-Immunocore CEO Eliot Forster as leader 1 year after FDA snub, advisory committee recommends AcelRx's Dsuvia for approval 10-3 HiFiBiO buys up H-Immune, joining forces to ‘combat cancer’ Microsoft turns to the microbiome with Eagle Genomics partnership Featured Story | Monday, October 15, 2018 Roche has committed $125 million in upfront and near-term payments to expand its partnership with SQZ Biotechnologies. The revised deal sets Roche up to work with SQZ on antigen-presenting cells designed to trigger killer T cell attacks against tumors. |
|
| This week's sponsor is BDO. | Think you’re ready to go public? Make sure you know the genome of the IPO first. Biotech IPOs are on a hot streak this year. But transforming to a public entity is not an easy undertaking. Biotechs should consider four steps ahead of IPO consideration—including bridging the gap between talent and governance. Read our Biotech IPO Checklist. | Top Stories Monday, October 15, 2018 Alnylam says it will wait for the final results of a phase 3 trial of acute hepatic porphyria drug givosiran before filing, rather than pressing ahead on the strength of interim results. Monday, October 15, 2018 Neurological biotech Redpin Therapeutics has snagged Eli Lilly veteran David Bleakman, Ph.D., as its new chief scientific officer. Monday, October 15, 2018 F-star has named ex-Immunocore CEO Eliot Forster as its new leader. The appointment puts a CEO known for raising huge sums of cash in charge of a well-regarded bispecific antibody R&D shop that has funded its progress to date through savvy dealmaking. Monday, October 15, 2018 An FDA advisory committee recommended AcelRx's Dsuvia, a sublingual version of sufentanil, for approval in a 10-3 vote. The meeting came exactly one year after the FDA declined to approve the drug. Monday, October 15, 2018 HiFiBiO Therapeutics has had a busy year, as pacts and raises abound, and it’s showing no signs of slowing down as it gets its checkbook out for an unusual French spinout. Monday, October 15, 2018 Microsoft has signed on to its first partnership exploring the genomics of the microbiome—with plans to construct an enterprise research platform examining immune disorders, antibiotic resistance and more—through a team-up with bioinformatics software developer Eagle Genomics. This week's sponsor is the Fierce Innovation Awards – Life Sciences Edition. | | | Enrollment Showcase | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
| | Sponsored by: Biotech Primer Drug Development Immersion is an intensive two-day course focused on the regulatory, commercial and scientific considerations required to bring a drug successfully to market. Learn from an industry expert who has received drug approvals in both the US and Europe. Register today! |
|
| Resources Sponsored by: Veeva Industry Research: Read the 2018 Unified Clinical Operations Report to find out how pharmas and CROs are evolving clinical trial processes. Sponsored by: SAP Collaborate in a digital world to improve patient outcomes. Sponsored by: Patheon, part of Thermo Fisher Scientific Read this whitepaper to learn more about two main areas where a drug developer can face significant obstacles during biologics development. Sponsored by: RWS Life Sciences Examine the linguistic and cultural considerations of global eCOA and BYOD. Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Compliance Certification Program at Seton Hall Law October 8-11, 2018 | Newark, NJ BioImmersion: Biotech for the Non-Scientist October 16-18, 2018 | Chicago, IL Fierce Innovation Awards: Life Sciences Edition 2018 Welcome to the inaugural Neuromuscular Drug Development Summit October 29-31, 2018 | Boston, MA, USA FierceBiotech Executive Summit: London October 30, 2018 | Royal Society of Medicine Drug Development Immersion November 1-2, 2018 | Boston, MA European Healthcare Compliance Certification Program November 5-8, 2018 | Paris, France Understanding Commercialization Within Biopharma Nov 7-8, 2018 | Boston, MA Drug Development Boot Camp® 2018 – Registration closes 30 October - Register Now! November 14-15, 2018 | Boston, MA | Registration closes on the 30 of October 2018 due to the need for participants to complete pre-Boot Camp preparations. Register now and start preparing for this intensive training in drug development. BioBasics: Biotech For The Non-Scientist December 5-6, 2018 | Boston, MA Drug Development Immersion December 5-6, 2018 | San Diego, CA Understanding Drug Pricing and Reimbursement December 12, 2018 | Boston, MA T Cell Based Immunotherapy: A Deeper Dive III Conference February 28 - March 3, 2019 |